The medical world is seeing a significant shift in diabetes therapy with the arrival of GLP-1 skin applications. These devices offer a seemingly more convenient alternative to subcutaneous administrations of GLP-1 drugs, minimizing the frequency of daily needle pricks. The approach administers th